Nano Therapy  Market Research Report - Global Forecast Till 2027

Nano Therapy Market Research Report: By Technology (Nanomaterial And Biological Device, Nano Electronic Biosensor, Molecular Nanotechnology, Implantable Cardioverter-Defibrillators), By Application (Cardiovascular Disease, Cancer Therapy, Diabetes Treatment, Rheumatoid Arthritis), By End User (Hospitals, Clinics And Research Institutions) - Global Forecast Till 2027

ID: MRFR/LS/0419-HCR | February 2021 | Region: Global | 100 pages

Please note that the assessment period of report has been updated from 2017–2023 to 2020-2027. Cordially fill the sample form for updated data.

Market Scenario


Nanotechnology has the potential to improve the drug solubility, stability, half-lives, and efficiency of the treatment. Nano therapy is a modern technique for treatment of various diseases and performed with the help of submicron sized molecular devices or nanoparticles. Nanotechnology offers the possibility to enhance drug dissolvability and strength, drag out medication half-lives in plasma, minimize off target impacts, and gather drugs at an objective site. This technology is characterized as submicron estimated atomic gadgets or nanoparticles prevalently running from 5 to 500 nm in one dimension. Generous past exploration exertion has brought about techniques to fuse helpful operators into biocompatible Nano devices including polymer nanoparticles, liposomes, micelle frameworks, inorganic nanoparticles, nanotubes, and dendrites.


The market for Nano-therapy is blooming, as of now, around 250 Nano-medical products are being tested or used for humans. Nano therapy is majorly used in the treatment of diseases such as cancer, diabetes, cardiovascular disease and others. The major driving factors for the growth of the market are increasing the prevalence of cancer and other metabolic diseases. A recent study conducted by the Journal of Diabetes and Metabolic diseases has suggested the prevalence of MS ranged from 35.8 to 45.3 % in India and 30.5 to 31.5 % in China. Moreover, continuous development in technology, increasing demand for the better treatment, government support for research and development, and increasing healthcare expenditure of the people have fueled the growth of Nano therapy market. However, lack of regulatory standards in the examination of Nano therapy and higher cost of the treatment are the major factors that may restrict the growth of the market.


The global Nano therapy market is expected to grow at a CAGR of 8.2% during the forecast period 2017-2023.


Key Players for Global Nano Therapy Market


Some of the major players for the market are Smith and Nephew (UK), Selecta Biosciences, Inc. (US), Sirnaomics, Inc. (US), Tarveda Therapeutics (US), DIM (US), Cristal Therapeutics (the Netherland), CytImmune Science, Inc. (US), Luna (US), NanoBio Corporation (US), NanoBioMagnetics.n.nu (US), Nanobiotix (France), Nanoprobes, Inc. (US), Parvus Therapeutics (US), Nanospectra Biosciences, Inc (US), Nanosphere Inc. (US), NanoMedia Solutions Inc. (Japan).


Segmentation


The global Nano therapy market is segmented on the basis of technologies, applications and end users. On the basis of technology, the market is further segmented into nanomaterial and biological devices, Nano electronic biosensors, molecular nanotechnology, implantable cardioverter-defibrillators, and other. On the basis of applications, the market is segmented into cardiovascular disease, cancer therapy, diabetes treatment, rheumatoid arthritis, and others. On the basis of end users, the market is further divided into hospitals, clinics and research institutions.


 Regional Analysis


America dominates the global Nano therapy market owing to large diabetic population. According to National Diabetes Statistics Report, 2017, around 30.3 million people of all ages that is nearly 9.4% of the U.S. population had diabetes in 2015. Moreover, the accessibility of technology, increasing healthcare expenditure, and increasing government support for the research and development are some more factors supporting the growth in this region. Europe is the second largest nanotherapy markets, which is majorly driven by awareness and advancement in the nanotechnology sector. Asia Pacific is the fastest growing market owing to increasing demand for the better treatment options, and rising initiatives to include IT healthcare sector. Whereas, due to less development in technology, and low infrastructure level the market for Middle East & Africa will have limited growth in the nanotherapy market.


 Figure 1- Global Nano Therapy Market, by application Nano therapy Market


Source- U.S. Department of Health and Human Services, National Institutes of Health, National Cancer Institute,  National Center for Biotechnology Information, U.S. National Library of Medicine Annual reports, press release, white paper, company presentation


 Intended Audience



  • Nano Medical Devices Manufacturer and Supplier

  • Research and Development (R&D) Companies

  • Independent Research Laboratories

  • Market Research And Consulting Service Providers

  • Medical Research Laboratories

  • Academic Medical Institutes And Universities



Frequently Asked Questions (FAQ) :


nano therapy market is projected to grow at an 8.2% CAGR between 2017-2023.

The Americas is projected to lead the nano therapy market.

Nano therapy finds extensive applications in rheumatoid arthritis, diabetes treatment, cancer therapy, cardiovascular disease, among others.

Increasing healthcare expenditure and rising prevalence of cancer are the key factors boosting the nano therapy market growth.

High treatment cost and lack of regulatory standards may restrict the nano therapy market growth.

TABLE OF CONTENTS

1 INTRODUCTION

1.1 DEFINITION

1.2 SCOPE OF STUDY

1.2.1 RESEARCH OBJECTIVE

1.2.2 ASSUMPTIONS & LIMITATIONS

1.2.2.1 ASSUMPTIONS

1.2.2.2 LIMITATIONS

1.3 MARKET STRUCTURE:

2 RESEARCH METHODOLOGY

2.1 RESEARCH PROCESS:

2.2 PRIMARY RESEARCH

2.3 SECONDARY RESEARCH:

3 MARKET DYNAMICS

3.1 DRIVERS

3.2 RESTRAINTS

3.3 OPPORTUNITIES

3.4 MACROECONOMIC INDICATORS

4 MARKET FACTOR ANALYSIS

4.1 PORTERS FIVE FORCES MODEL

4.2 BARGAINING POWER OF SUPPLIERS

4.3 BARGAINING POWER OF BUYERS

4.4 THREAT OF NEW ENTRANTS

4.5 THREAT OF SUBSTITUTES

4.6 INTENSITY OF RIVALRY

5. GLOBAL NANO THERAPY MARKET, BY TECHNOLOGY

5.1 NANOMATERIAL AND BIOLOGICAL DEVICE

5.2 NANO ELECTRONIC BIOSENSOR

5.3 MOLECULAR NANOTECHNOLOGY

5.4 IMPLANTABLE CARDIOVERTER-DEFIBRILLATORS

5.5 OTHER

6. GLOBAL NANO THERAPY MARKET, BY APPLICATION

6.1 CARDIOVASCULAR DISEASE

6.2 CANCER THERAPY

6.3 DIABETES TREATMENT

6.4 RHEUMATOID ARTHRITIS

6.5 OTHER

7. GLOBAL NANO THERAPY MARKET, BY END USERS

7.1 HOSPITAL

7.2 CLINICS

7.3 RESEARCH LABORATORIES

8. GLOBAL NANO THERAPY MARKET, BY REGION

8.1 INTRODUCTION

8.2 AMERICA

8.2.1 NORTH AMERICA

8.2.1.1 US

8.2.1.2 CANADA

8.2.2 SOUTH AMERICA

8.3 EUROPE

8.3.1 WESTERN EUROPE

8.3.1.1 GERMANY

8.3.1.2 FRANCE

8.3.1.3 ITALY

8.3.1.3 SPAIN

8.3.1.5 UK

8.3.1.6 REST OF WESTERN EUROPE

8.3.2 EASTERN EUROPE

8.4 ASIA PACIFIC

8.4.1 JAPAN

8.4.2 CHINA

8.4.3 INDIA

8.4.4 AUSTRALIA

8.4.5 REPUBLIC OF KOREA

8.4.6 REST OF ASIA-PACIFIC

8.5 MIDDLE EAST & AFRICA

8.5.1 UNITED ARAB EMIRATES

8.5.2 SAUDI ARABIA

8.5.3 OMAN

8.5.4 KUWAIT

8.5.5 QATAR

8.5.6 REST OF THE MIDDLE EAST & AFRICA

9. COMPETITIVE LANDSCAPE

9.1 MAJOR STRATEGIES ADOPTED BY MARKET PLAYERS

9.1.1 STRATEGIC PARTNERSHIP

9.1.2 MERGER & ACQUISITION

10 COMPANY PROFILE

10.1 NANOPROBES, INC

10.1.1 OVERVIEW

10.1.2 PRODUCT OVERVIEW

10.1.3 FINANCIALS

10.1.4 KEY DEVELOPMENTS

10.2 NANOSPECTRA BIOSCIENCES, INC

10.2.1 OVERVIEW

10.2.2 PRODUCT OVERVIEW

10.2.3 FINANCIALS

10.2.4 KEY DEVELOPMENTS

10.3 PARVUS THERAPEUTICS

10.3.1 OVERVIEW

10.3.2 PRODUCT OVERVIEW

10.3.3 FINANCIALS

10.3.4 KEY DEVELOPMENT

10.4 SMITH AND NEPHEW

10.4.1 OVERVIEW

10.4.2 PRODUCT OVERVIEW

10.4.3 FINANCIALS

10.4.4 KEY DEVELOPMENTS

10.5 SELECTA BIOSCIENCES, INC.

10.5.1 OVERVIEW

10.5.2 PRODUCT OVERVIEW

10.5.3 FINANCIALS

10.5.4 KEY DEVELOPMENTS

10.6 SIRNAOMICS, INC.

10.6.1 OVERVIEW

10.6.2 PRODUCT OVERVIEW

10.6.3 FINANCIALS

10.6.4 KEY DEVELOPMENTS

10.7 TARVEDA THERAPEUTICS

10.7.1 OVERVIEW

10.7.2 PRODUCT OVERVIEW

10.7.3 FINANCIALS

10.7.4 KEY DEVELOPMENTS

10.8 SIRNAOMICS, INC

10.8.1 OVERVIEW

10.8.2 PRODUCT OVERVIEW

10.8.3 FINANCIALS

10.8.4 KEY DEVELOPMENT

10.9 OTHERS

11 CONCLUSION

11.1 KEY FINDINGS

11.1.1 FROM CEO’S VIEWPOINT

11.1.2 UNMET NEEDS OF THE MARKET

11.2 KEY COMPANIES TO WATCH

11.3 PREDICTION OF NANOTECHNOLOGY INDUSTRIES

12 APPENDIX

LIST OF TABLES

Table 1 Nano Therapy Industry Synopsis, 2020-2027

Table 2 Global Nano Therapy Market Estimates and Forecast, 2020-2027, (USD Million)

Table 3 Global Nano Therapy Market by Region, 2020-2027, (USD Million)

Table 4 Global Nano Therapy Market by Technology, 2020-2027, (USD Million)

Table 5 Global Nano Therapy Market by Application, 2020-2027, (USD Million)

Table 6 Global Nano Therapy Market by End Users, 2020-2027, (USD Million)

Table 7 North America Nano Therapy Market by Technology, 2020-2027, (USD Million)

Table 8 North America Nano Therapy Market by Application, 2020-2027, (USD Million)

Table 9 North America Nano Therapy Market by End User, 2020-2027, (USD Million)

Table 10 US Nano Therapy Market by Technology, 2020-2027, (USD Million)

Table 11 US Nano Therapy Market by Application, 2020-2027, (USD Million)

Table 12 US Nano Therapy Market by End User, 2020-2027, (USD Million)

Table 13 Canada Nano Therapy Market by Technology, 2020-2027, (USD Million)

Table 14 Canada Nano Therapy Market by Application, 2020-2027, (USD Million)

Table 15 Canada Nano Therapy Market by End User, 2020-2027, (USD Million)

Table 16 South America Nano Therapy Market by Technology, 2020-2027, (USD Million)

Table 17 South America Nano Therapy Market by Application, 2020-2027, (USD Million)

Table 18 South America Nano Therapy Market by End User, 2020-2027, (USD Million)

Table 19 Europe Nano Therapy Market by Technology, 2020-2027, (USD Million)

Table 20 Europe Nano Therapy Market by Application, 2020-2027, (USD Million)

Table 21 Europe Nano Therapy Market by End User, 2020-2027, (USD Million)

Table 22 Western Europe Nano Therapy Market by Technology, 2020-2027, (USD Million)

Table 23 Western Europe Nano Therapy Market by Application, 2020-2027, (USD Million)

Table 24 Western Europe Nano Therapy Market by End User, 2020-2027, (USD Million)

Table 25 Eastern Europe Nano Therapy Market by Technology, 2020-2027, (USD Million)

Table 26 Eastern Europe Nano Therapy Market by Application, 2020-2027, (USD Million)

Table 27 Eastern Europe Nano Therapy Market by End User, 2020-2027, (USD Million)

Table 28 Asia Pacific Nano Therapy Market by Technology, 2020-2027, (USD Million)

Table 29 Asia Pacific Nano Therapy Market by Application, 2020-2027, (USD Million)

Table 30 Asia Pacific Nano Therapy Market by End User, 2020-2027, (USD Million)

Table 31 Middle East & Africa Nano Therapy Market by Technology, 2020-2027, (USD Million)

Table 32 Middle East & Africa Nano Therapy Market by Application, 2020-2027, (USD Million)

Table 33 Middle East & Africa Nano Therapy Market by End User, 2020-2027, (USD Million)

LIST OF FIGURES

Figure 1 Research Process

Figure 2 Segmentation for Global Nano Therapy Market

Figure 3 Segmentation Market Dynamics for Nano Therapy Market

Figure 4 Global Nano Therapy Market Share, by Technology 2020

Figure 5 Global Nano Therapy Market Share, by Application 2020

Figure 6 Global Nano Therapy Market Share, by End Users, 2020

Figure 7 Global Nano Therapy Market Share, by Region, 2020

Figure 8 North America Nano Therapy Market Share, by Country, 2020

Figure 9 Europe Nano Therapy Market Share, by Country, 2020

Figure 10 Asia Pacific Nano Therapy Market Share, by Country, 2020

Figure 11 Middle East & Africa Nano Therapy Market Share, by Country, 2020

Figure 12 Global Nano Therapy Market: Company Share Analysis, 2020 (%)

Figure 13 Smith and Nephew: Key Financials

Figure 14 Smith and Nephew: Segmental Revenue

Figure 16 Smith and Nephew: Geographical Revenue

Figure 17 Selecta Biosciences, Inc..: Key Financials

Figure 18 Selecta Biosciences, Inc. Segmental Revenue

Figure 19 Selecta Biosciences, Inc. Geographical Revenue

Figure 20 Sirnaomics, Inc..: Key Financials

Figure 21 Sirnaomics, Inc..: Segmental Revenue

Figure 22 Sirnaomics, Inc..: Geographical Revenue

Figure 23 Tarveda Therapeutics: Key Financials

Figure 24 Tarveda Therapeutics: Segmental Revenue

Figure 25 Tarveda Therapeutics: Geographical Revenue

Figure 26 DIM: Key Financials

Figure 27 DIM: Segmental Revenue

Figure 28 DIM: Geographical Revenue

Figure 29 CytImmune Science, Inc.: Key Financials

Figure 30 CytImmune Science, Inc.: Segmental Revenue

Figure 31 CytImmune Science, Inc.: Geographical Revenue

Figure 32 Luna NanoBio Corporation: Key Financials

Figure 33 Luna NanoBio Corporation: Segmental Revenue

Figure 34 Luna NanoBio Corporation: Geographical Revenue

Figure 35 Others